-
Charges
A charge with Others of Rs. 20.00 Cr registered on 28 Nov 2024 with Charge ID 101019799 was modified on 08 Jul 2025. was recorded as a recent event.
-
Charges
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101124289 was registered on 05 May 2025. was completed.
-
Charges
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.16 Cr with Charge ID 101082617 was registered on 07 Feb 2025. was documented.
-
Charges
Progress on A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101019799 was registered on 28 Nov 2024. was documented.
-
Annual General Meeting
Maithri Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
-
Charges
The activity A charge with Sidbi amounted to Rs. 1.23 Cr with Charge ID 100983321 was registered on 27 Sep 2024. was completed.
Maithri Drugs Private Limited, a active private limited company, was established on 18 February 2013 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24100TG2013PTC085821. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 506 professional, Its leadership includes Naga Vikas Chakilam (Director), Naga Raju Chakilam (Director). Past directors included Satyanarayana Reddy Manne. It holds ₹87.55 Cr open charges and ₹13.28 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Dwaraka Signature, 2Nd Floor, Plot No. 14D/1 Survey No. 74 And 75, Jaihind Enclave, M, Adhapur, Hyderabad, Telangana, 500081.
Company Details
- CIN/LLPIN
U24100TG2013PTC085821
- Registration Number
085821
- Incorporation Date
18 February 2013
- Authorized Capital
₹1.00 Cr
- Paid-Up Capital
₹1.00 Cr
- ROC Code
Roc Hyderabad
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 87.55 Cr
- Satisfied Charges ₹ 13.28 Cr
- Revenue Growth 6.15%
- Profit Growth 81.22%
- Ebitda 55.07%
- Net Worth 32.39%
- Total Assets 14.74%
Maithri Drugs Private Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Maithri Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naga Vikas Chakilam | Director | 31 Mar 2018 | Current |
| Naga Raju Chakilam | Director | 18 Feb 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maithri Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.15% increase. The company also saw a substantial improvement in profitability, with a 81.22% increase in profit. The company's net worth Soared by an impressive increase of 32.39%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
In 2023, Maithri Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
₹875,525,317.00
₹132,800,000.00
- Axis Bank Limited : 66.01 Cr
- Others : 20.00 Cr
- Sidbi : 1.23 Cr
- Hdfc Bank Limited : 0.31 Cr
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2025 | Hdfc Bank Limited | ₹1.52 M | Open |
| 07 Feb 2025 | Hdfc Bank Limited | ₹1.62 M | Open |
| 28 Nov 2024 | Others | ₹20.00 Cr | Open |
| 27 Sep 2024 | Sidbi | ₹1.23 Cr | Open |
| 09 Jan 2023 | Axis Bank Limited | ₹1.11 Cr | Open |
Explore comprehensive loan charge details -
Maithri Drugs has a workforce of 506 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Maithri Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maithri Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Maithri Drugs Private Limited?
The CIN of Maithri Drugs Private Limited is U24100TG2013PTC085821.
Where is Maithri Drugs Private Limited headquartered?
Maithri Drugs Private Limited is headquartered at Dwaraka Signature, 2Nd Floor, Plot No. 14D/1 Survey No. 74 And 75, Jaihind Enclave, M, Adhapur, Hyderabad, Telangana, 500081.
When was Maithri Drugs Private Limited incorporated?
Maithri Drugs Private Limited was incorporated on 18 February 2013.
Who are the current directors of Maithri Drugs Private Limited?
The current directors of Maithri Drugs Private Limited are
What is the primary industry of Maithri Drugs Private Limited?
The primary industry of Maithri Drugs Private Limited is Manufacturing.
Is Maithri Drugs Private Limited a listed company?
Maithri Drugs Private Limited is unlisted.
What is the capital structure of Maithri Drugs Private Limited?
The authorized capital of Maithri Drugs Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
What is the compliance status of Maithri Drugs Private Limited?
The compliance status of Maithri Drugs Private Limited is Compliant.
+91-XXXXXXXXXX